Solence

Founded in 2022 and headquartered in Strasbourg, France, Solence develops a digital application specifically designed for women diagnosed with chronic conditions, particularly PCOS.Solence primarily offers a digital application designed to assist women in managing the symptoms of Polycystic Ovary Syndrome (PCOS). The app incorporates over 300 theoretical insights and actionable strategies, focusing on lifestyle modifications in areas such as nutrition, exercise, stress management, environmental health, sleep, and emotional well-being. By doing so, it aims to help users understand their symptoms and observe the potential health effects of the proposed lifestyle changes. The target clientele comprises women diagnosed with chronic conditions, specifically PCOS, who are seeking comprehensive support and solutions for better health outcomes.Solence's revenue model is based on subscription services tailored to individual users seeking ongoing support and guidance through the app. Clients typically engage with the platform through direct-to-consumer transactions, allowing them to access the app's features and resources on a recurring basis. The subscription structure includes various pricing plans that offer differing levels of access to the app's comprehensive content and features, ensuring continuous user engagement and fostering a relationship with the client base, which comprises women actively managing their health conditions. The company aims to enhance its application with new features and is focused on expanding its market presence in Europe and North America.

1. Seed

   Jul 2, 2025

   Amount

   $1.9M

   Investors

   Locked